StockData
Cadrenal Therapeutics, Inc. logo

Cadrenal Therapeutics, Inc. (CVKD) stock

CVKDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 9/30
$1.88+0.48 (+34.29%)

Close on Nov 17, 2026Market cap $6.71MP/E –Yield 877.66%

Earnings

Cadrenal Therapeutics's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Nov 9, 2026
Q3 FY2026 · estimated, before the open
Revenue, Q2 FY2025
–
EPS, Q2 FY2025
-$1.87
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Cadrenal Therapeutics's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q3 FY2026ended Sep 30, 2026Nov 9, 2026Expected––––
Q2 FY2026ended Jun 30, 2026Aug 13, 2026after the close–––Release
Q1 FY2026ended Mar 31, 2026May 7, 2026before the open–––Release
Q4 FY2025ended Dec 31, 2025Mar 31, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Nov 10, 2025before the open–––Release
Q2 FY2025ended Jun 30, 2025Aug 11, 2025after the close––-$1.87Release
Q1 FY2025ended Mar 31, 2025May 8, 2025after the close–––Release
Q4 FY2024ended Dec 31, 2024Mar 13, 2025after the close–––Release
Q3 FY2024ended Sep 30, 2024Nov 7, 2024before the open–––Release
Q2 FY2024ended Jun 30, 2024Aug 8, 2024after the close–––Release
Q4 FY2023ended Dec 31, 2023Mar 11, 2024before the open–––Release
Q3 FY2023ended Sep 30, 2023Nov 9, 2023before the open–––Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Cadrenal Therapeutics has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Cadrenal Therapeutics puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Cadrenal Therapeutics filed with the SEC as exhibits to Form 8-K or 6-K

  1. Update
  2. Update
  3. Results
  4. Update
  5. News
  6. Update
  7. Results
  8. Update
  9. Results
  10. Update
  11. News
  12. Update
  13. Update
  14. News
  15. Results

See a number that looks wrong?